Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder

Journal of Affective Disorders

Volumn 150, Issue 2, 2013, Pages 456-459

  Dickerson, Faith ^a   Stallings, Cassie ^a   Origoni, Andrea ^a   Vaughan, Crystal ^a   Khushalani, Sunil ^a   Yolken, Robert ^b  

^a Stanley Research Program at Sheppard Pratt   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; C reactive protein; Cognitive; Herpes simplex virus type 1; Immune response; Inflammatory marker

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; ATTENTION; AUTOIMMUNE DISEASE; BIPOLAR DISORDER; BODY MASS; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; SCORING SYSTEM; SHORT TERM MEMORY; SMOKING; WECHSLER INTELLIGENCE SCALE;

BIPOLAR DISORDER; C-REACTIVE PROTEIN; COGNITIVE; HERPES SIMPLEX VIRUS TYPE 1; IMMUNE RESPONSE; INFLAMMATORY MARKER;

ADULT; BIPOLAR DISORDER; C-REACTIVE PROTEIN; COGNITION DISORDERS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; YOUNG ADULT;

EID: 84882853156     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.04.039     Document Type: Article

References (28)

1. M. Azar, E. Valentin, G. Badaoui, R. Kassab, A. Sarkis, and R.R. Azar Comparison of the effects of combination atorvastatin (40 mg)+ezetimibe (10 mg) versus atorvastatin (40 mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent American Journal of Cardiology 107 2011 1571 1574
2. F. Dickerson, J.J. Boronow, C. Stallings, A.E. Origoni, S.K. Cole, and R.H. Yolken Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status Psychiatry Research 129 2004 45 53
3. F. Dickerson, C. Stallings, A. Origoni, J. Boronow, and R. Yolken C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia Schizophrenia Research 93 2007 261 265
4. F. Dickerson, C. Stallings, A. Origoni, C. Vaughan, S. Khushalani, and R. Yolken Additive effects of elevated C-reactive protein and exposure to Herpes simplex virus type 1 on cognitive impairment in individuals with schizophrenia Schizophrenia Research 134 2012 83 88
5. F.B. Dickerson, J.J. Boronow, C. Stallings, A.E. Origoni, S. Cole, B. Krivogorsky, and R.H. Yolken Infection with Herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder Biological Psychiatry 55 2004 588 593
6. F.B. Dickerson, J.J. Boronow, C. Stallings, A.E. Origoni, S. Cole, F. Leister, B. Krivogorsky, and R.H. Yolken The catechol O-methyltransferase Val158Met polymorphism and Herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder Bipolar Disorder 8 2006 124 132
7. F.B. Dickerson, J.J. Boronow, C. Stallings, A.E. Origoni, I. Ruslanova, and R.H. Yolken Association of serum antibodies to Herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia Archives of General Psychiatry 60 2003 466 472
8. F.B. Dickerson, J.J. Boronow, C.R. Stallings, A.E. Origoni, S. Cole, and R.H. Yolken Association between cognitive functioning and employment status of persons with bipolar disorder Psychiatric Services 55 2004 54 58
9. N. Dimopoulos, C. Piperi, A. Salonicioti, P. Mitropoulos, E. KAallai, I. Liappas, R.W. Lea, and A. Kalofoutis Indices of low-grade chronic inflammation correlate with early cognitive deterioration in an elderly Greek population Neuroscience Letters 398 2006 118 123
10. I.N. Ferrier, B.R. Stanton, T.P. Kelly, and J. Scott Neuropsychological function in euthymic patients with bipolar disorder British Journal of Psychiatry. 175 1999 246 251
11. M. First, M Gibbon, R.L. Spitzer, and J.B.W Williams Structured clinical interview for DSM-IV disorders - non-patient edition, New York Biometrics Research 1998
12. M. First, M. Gibbon, R.L. Spitzer, and J.B.W Williams User's guide for the SCID-I, structured clinical interview for DSM IV axis I disorders, New York, NY Biometrics Research 1996
13. J. Gunstad, L. Bausserman, R.H. Paul, D.F. Tate, K. Hoth, A. Poppas, A.L. Jefferson, and R.A. Cohen C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease Journal of Clinical Neuroscience 13 2006 540 546
14. M. Hamilton Development of a rating scale for primary depressive illness British Journal of Clinical Psychology 6 1967 278 296
15. M.P. Hobart, R. Goldberg, J.J. Bartko, and J.M. Gold Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons American Journal of Psychiatry 156 1999 1951 1957
16. L. Krabbendam, A. Honig, J. Wiersma, E.F. Vuurman, P.A. Hofman, M.M. Derix, W.A. Nolen, and J. Jolles Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission Acta Psychiatrica Scandinavica 101 2000 274 280
17. G.D. Lowe Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease Journal of Thrombosis and Haemostasis 3 2005 1618 1627
18. A. Martinze-Aran, E. Vieta, F. Colom, M. Reinares, A. Benabarre, C. Gasto, and M. Salamero Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances Psychotherapy and Psychosomatics 69 2000 2 18
19. S. Quraishi, and S. Frangou Neuropsychology of bipolar disorder: a review Journal of Affective Disorders 72 2002 209 226
20. B. Ramlawi, J.L. Rudolph, S. Mieno, K. Khabbaz, N.R. Sodha, M. Boodhwani, S.E. Levkoff, E.R. Marcantonio, and F.W. Sellke Serologic markers of brain injury and cognitive function after cardiopulmonary bypass Annals of Surgery 244 2006 593 601
21. C. Randolph, M.C. Tierney, E. Mohr, and T.N. Chase The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity Journal of Clinical and Experimental Neuropsychology 20 1998 310 319
22. G. Ravaglia, P. Forti, F. Maioli, N. Brunetti, M. Martelli, L. Servadei, L. Bastagli, M. Bianchin, and E. Mariani Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60 2005 1017 1021
23. R. Reitan Manual for Administration of Neuropsychological Test Batteries for Adults and Children 1979 Tucson Arizona
24. D. Rubin Multiple imputation after 18+ years Journal of the American Statistical Association 91 1996 473 489
25. E.M. Sanchez-Morla, A. Barbash, V. Martinze-Vizcaino, R. Tabres-Seisedos, V. Balanza-Martinez, J.A. Cabranes-Diaz, E. Baca-Baldomero, and J.L. Gomez Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients Psychiatry Research 169 2009 220 228
26. W.G. Van Gorp, L. Altshuler, D.C. Theberge, J. Wilkins, and W. Dixon Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study Archives of General Psychiatry 55 1998 41 46
27. Wechsler, D. 1997. Wecshler Adult Intelligence Scale III, San Antonio Texas, Psychological Corporation.
28. R.C. Young, J.T. Biggs, V.E. Ziegler, and D.A. Meyer A rating scale for mania: reliability, validity and sensitivity British Journal of Psychiatry 133 1978 429 435